Moens A - Search Results

1

Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study.

Vanoli A, Guerini C, Arpa G, Klersy C, Grillo F, Casadei Gardini A, De Hertogh G, Ferrante M, Moens A, Furlan D, Sessa F, Quaquarini E, Lenti MV, Neri G, Macciomei MC, Fassan M, Cascinu S, Paulli M, Graham RP, Di Sabatino A. Vanoli A, et al. Among authors: moens a. Dig Liver Dis. 2023 Sep;55(9):1261-1269. doi: 10.1016/j.dld.2023.05.005. Epub 2023 May 24. Dig Liver Dis. 2023. PMID: 37236851

2

Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy.

Ferrante M, de Buck van Overstraeten A, Schils N, Moens A, Van Assche G, Wolthuis A, Vermeire S, D'Hoore A. Ferrante M, et al. Among authors: moens a. J Crohns Colitis. 2017 Oct 27;11(11):1353-1361. doi: 10.1093/ecco-jcc/jjx095. J Crohns Colitis. 2017. PMID: 28981886

3

Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades.

Moens A, Verstockt B, Machiels K, Bossuyt P, Verdonck A, Lagrou K, van Assche G, Vermeire S, Ferrante M. Moens A, et al. Eur J Gastroenterol Hepatol. 2019 Jun;31(6):668-673. doi: 10.1097/MEG.0000000000001394. Eur J Gastroenterol Hepatol. 2019. PMID: 30839436

4

Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.

Bronswijk M, Moens A, Lenfant M, Tops S, Compernolle G, Van Assche G, Vermeire S, Gils A, Ferrante M. Bronswijk M, et al. Among authors: moens a. Inflamm Bowel Dis. 2020 Mar 4;26(4):628-634. doi: 10.1093/ibd/izz167. Inflamm Bowel Dis. 2020. PMID: 31400283

5

Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

Dubois E, Moens A, Geelen R, Sabino J, Ferrante M, Vermeire S. Dubois E, et al. Among authors: moens a. United European Gastroenterol J. 2020 Oct;8(8):933-941. doi: 10.1177/2050640620941345. Epub 2020 Jul 6. United European Gastroenterol J. 2020. PMID: 32631177 Free PMC article.

6

Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.

Moens A, Verstockt B, Alsoud D, Sabino J, Ferrante M, Vermeire S. Moens A, et al. Inflamm Bowel Dis. 2022 Aug 1;28(8):1135-1142. doi: 10.1093/ibd/izab257. Inflamm Bowel Dis. 2022. PMID: 34751766

7

Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre.

Moens A, Sadat Seyed Tabib N, Ballet V, Sabino J, Vermeire S, Ferrante M. Moens A, et al. Aliment Pharmacol Ther. 2022 Jul;56(2):271-281. doi: 10.1111/apt.16928. Epub 2022 Apr 20. Aliment Pharmacol Ther. 2022. PMID: 35441398

8

Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center.

Moens A, Alsoud D, Verstockt B, Sabino J, Ferrante M, Vermeire S. Moens A, et al. Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1015-1020. doi: 10.1097/MEG.0000000000002411. Epub 2022 Aug 30. Eur J Gastroenterol Hepatol. 2022. PMID: 36062494

9

A Clinicopathologic Comparison Between Early-Onset and Late-Onset Small Bowel Adenocarcinoma: A Multicenter International Study.

Arpa G, Vanoli A, Antoci F, Lenti MV, Di Sabatino A; and the Small Bowel Carcinoma Consortium. Arpa G, et al. Am J Gastroenterol. 2024 Jan 1. doi: 10.14309/ajg.0000000000002585. Online ahead of print. Am J Gastroenterol. 2024. PMID: 37966091

10

IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasia.

Guerini C, Furlan D, Ferrario G, Grillo F, Libera L, Arpa G, Klersy C, Lenti MV, Riboni R, Solcia E, Fassan M, Mastracci L, Ardizzone S, Moens A, De Hertogh G, Ferrante M, Graham RP, Sessa F, Paulli M, Di Sabatino A, Vanoli A. Guerini C, et al. Among authors: moens a. Histopathology. 2024 Feb;84(3):515-524. doi: 10.1111/his.15095. Epub 2023 Nov 21. Histopathology. 2024. PMID: 37988281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page